APTX - Aptinyx Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-12.65M

Cash

44.57M

Avg Qtr Burn

-13.78M

Short % of Float

4.32%

Insider Ownership

13.13%

Institutional Own.

42.97%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NYX-783 Details Psychiatric disorder, Post-traumatic stress disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NYX-2925 Details Central nervous system illness, Fibromyalgia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NYX-458 Details Central nervous system illness, Mental health, Parkinson's disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
NYX-2925 Details Diabetic peripheral neuropathy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.